Kyle Bass: EMs Will Falter, Next Two Years Will Be Tough

0
Kyle Bass: EMs Will Falter, Next Two Years Will Be Tough


Kyle Bass, Hayman Capital Management founder and managing partner, explains his confidence in sounding the alarm over emerging markets.

Kyle Bass: EMs Will Falter, Next Two Years Will Be Tough

China’s $3T Banking Loss Just Beginning: Bass

Kyle Bass, Hayman Capital Management founder and managing partner, calls attention to a real problem he sees with banking sectors across Asia.

Seth Klarman’s 2021 Letter: Baupost’s “Never-Ending” Hunt For Information

Baupost's investment process involves "never-ending" gleaning of facts to help support investment ideas Seth Klarman writes in his end-of-year letter to investors. In the letter, a copy of which ValueWalk has been able to review, the value investor describes the Baupost Group's process to identify ideas and answer the most critical questions about its potential Read More

Biopharma Lobbying Making This A Big Fight: Bass

Kyle Bass, Hayman Capital Management founder and managing partner, discusses the criticism he is facing as he takes on drug patents.

Fight Against Big Pharma Not About Just Profiting: Bass

Kyle Bass, Hayman Capital Management founder and managing partner, discusses the reasons behind why he’s bringing challenges to drug patents.

Updated on

Sheeraz is our COO (Chief - Operations), his primary duty is curating and editing of ValueWalk. He is main reason behind the rapid growth of the business. Sheeraz previously ran a taxation firm. He is an expert in technology, he has over 5.5 years of design, development and roll-out experience for SEO and SEM. - Email: sraza(at)valuewalk.com
Previous article Pentair, Cardica, Casella Waste Systems: This Week In Activism
Next article David Tepper Completes Huge Mansion In The Hamptons

No posts to display